Medicament formulation to combat trigeminus neuralgia - contains pyrazolone derivatives

摘要

Medicament comprises (mg.): phenyldimethyl isopropyl pyrazolone, 90; 1-phenyl-2,3-dimethyl-4-isopropyl-5-pyrazolone, 150; Na phenyldimethylpyrazolone methylaminomethane sulphonate, 35; 4-ethoxy-acetanilide, 150; beta-hydroxybutyryl-p-phenetidine, 30; phenacetin, 150; caffeine, 30; aneurine nitrate, 5; excipients (dextrose, Na alginate), 360 and inert carriers.